Straumann, CH0012280076

UBS upgrades Straumann stock and raises target to CHF 115.00

Published on 10/01/2026 at 11:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann posted CHF 1.38 billion in first-half 2026 sales, up 7.80 percent organically. Straumann stock faces its next earnings release on October 28, 2026.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen
Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann stock (ISIN CH0012280076) received a fresh analyst boost on September 1, 2026, when UBS upgraded the company from Neutral to Buy and raised its price target from CHF 90.00 to CHF 115.00, according to MarketScreener. The move came as Straumann's latest operating figures showed resilient demand and improving profitability.

UBS raises target to CHF 115

UBS lifted its 12-month target by CHF 25.00, a 27.78 percent increase from the previous CHF 90.00 target. The bank cited manageable risks, improving earnings momentum and an attractive valuation gap in its September 1, 2026 research view, as reported by MarketScreener.

The upgrade followed Straumann's half-year results for the period ended June 30, 2026. Sales reached CHF 1.38 billion, up 7.80 percent organically, while second-quarter organic growth accelerated to 8.50 percent, according to StockSentinel.

Margin expansion meets China risk

Core EBIT reached CHF 354.80 million in the first half of 2026, and the constant-currency core EBIT margin rose 1.20 percentage points to 26.90 percent. Management reaffirmed full-year 2026 guidance for high-single-digit organic growth and 140 to 170 basis points of core EBIT margin expansion, according to StockSentinel.

China remains the key counter-factor because volume-based procurement can pressure implant prices. UBS expects a second procurement round to bring a 10.00 to 15.00 percent price reduction, with volume gains potentially offsetting part of that pressure, according to Investing.com.

SIX quote and next report date

On SIX, Straumann was last at CHF 91.48 on October 1, 2026 at 11:29 a.m. CEST, within its CHF 73.02 to CHF 109.80 52-week range. The next earnings release is scheduled for October 28, 2026, according to MarketScreener.

Straumann stock facts

  • Company: Straumann Holding AG
  • ISIN: CH0012280076
  • Ticker: STMN
  • Primary exchange: SIX
  • Primary exchange quote: CHF 91.48 on October 1, 2026 at 11:29 a.m. CEST
  • 52-week range: CHF 73.02-109.80 as of October 1, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: October 28, 2026

More news and analyses on Straumann stock

Disclaimer...

en | CH0012280076 | STRAUMANN | boerse | 70209586 | bgmi